In vivo imaging of MMP‐13 activity using a specific polymer‐FRET peptide conjugate detects early osteoarthritis and inhibitor efficacy
Imaging early molecular changes in osteoarthritic (OA) joints is instrumental for the development of disease‐modifying drugs. To this end, a fluorescent resonance energy transfer‐based peptide probe that is cleavable by matrix metalloproteinase 13 (MMP‐13) has been developed. This protease degrades...
Main Authors: | Duro‐Castano, A, Lim, N, Tranchant, I, Amoura, M, Beau, F, Wieland, H, Kingler, O, Herrmann, M, Nazaré, M, Plettenburg, O, Dive, V, Vicent, M, Nagase, H |
---|---|
Format: | Journal article |
Published: |
Wiley
2018
|
Similar Items
-
Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain.
by: Stura, E, et al.
Published: (2013) -
In vivo imaging of MMP-13 activity in the murine destabilised medial meniscus surgical model of osteoarthritis.
by: Lim, N, et al.
Published: (2014) -
The second dimer interface of MT1-MMP, the transmembrane domain, is essential for ProMMP-2 activation on the cell surface.
by: Itoh, Y, et al.
Published: (2008) -
Quantum Dots (QD-Dye Conjugate) are Ideal Candidates for FRET Investigations Using TIRMicroscopy
by: Asma H. Mohammed
Published: (2014-04-01) -
Kinetic characterization of new selective collagenase 3 (MMP-13) inhibitors as potential therapeutic agents in osteoarthritis
by: Santamaria, S, et al.
Published: (2009)